Ads
related to: acute leukemia prognosis treatment mayo clinic chart- AML Information
Read More Information About
mIDH1 & Acute Myeloid Leukemia.
- Dosing & Management
Learn About Dosing For R/R mIDH1
Acute Myeloid Leukemia.
- FAQ Page
Additional Questions? Visit Our FAQ
Page For More Information.
- Connect with a Rep
Schedule an Appointment with
A Representative Today
- Access & Resources
HCPs - More Information & Resources
Are Available For You Here.
- Safety Information
HCPs - Read The Safety Profile Of
This AML Treatment Option.
- AML Information
Search results
Results From The WOW.Com Content Network
In childhood, T-cell acute lymphoblastic leukemia (T-ALL) patients can expect a 5-year event-free survival (EFS) rate of 70% and an overall survival (OS) rate of 80%. [1] Among the approximately 25% of children who relapse, survival rates drop to 30-50%, with patients generally showing a much poorer prognosis. [ 1 ]
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. [1] Symptoms may include feeling tired, pale skin color, fever, easy bleeding or bruising, enlarged lymph nodes, or bone pain. [1]
Specialty: Hematology and oncology: Symptoms: Bleeding, bruising, fatigue, fever, increased risk of infections [2] Usual onset: All ages, [3] most common in 60s and 70s. [4] It is the most common malignant cancer in children, but the cure rates are also higher for them.
Acute leukemia or acute leukaemia is a family of serious medical conditions relating to an original diagnosis of leukemia. In most cases, these can be classified according to the lineage, myeloid or lymphoid , of the malignant cells that grow uncontrolled, but some are mixed and for those such an assignment is not possible.
Biphenotypic acute leukaemia (BAL) is an uncommon type of leukemia which arises in multipotent progenitor cells which have the ability to differentiate into both myeloid and lymphoid lineages. [1] [2] [3] It is a subtype of "leukemia of ambiguous lineage". [4] The direct reasons leading to BAL are still not clear.
It is a rare disease, constituting about 2–5% of all leukemia cases. [1] It mostly involve myeloid with either of T lymphocyte or B lymphocyte progenitors, but in rare cases all the three cell lineages. [2] Knowledge on the cause, clinical features and cellular mechanism is poor, making the treatment and management (prognosis) difficult. [3]
Ad
related to: acute leukemia prognosis treatment mayo clinic chart